![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 28, 2018 2:47:59 AM
We are now back trading at a level that existed 12 months ago. Howwever back then Biel had not acheoved the following items which are now delivered:
- been granted FDA approval for two other category areas.
-Been put on the NHS UK Government insurance cover.
- Link to VA.
- Big deal with Mudipharma
- Product with CVS
These are big achievements abd it is not reflected in the share price.
Futhermore it is very clear that Biel will secure FDA approval for female application in the USA. We just need to wait a little longer.
Hence this is a big overreaction in share price drop.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM